Emergency department (ED)–based initiation of buprenorphine has been shown to increase engagement in outpatient treatment and reduce the risk of subsequent opioid overdose; however, rates of buprenorphine treatment in the ED and follow-up care for opioid use disorder (OUD) remain low in the U.S. In response to high opioid overdose death rates, the Pennsylvania Department of Human Services (DHS) implemented the Opioid Hospital Quality Improvement Program (O-HQIP) in 2019. The O-HQIP is the first statewide financial incentive program designed to increase engagement in OUD treatment, including buprenorphine treatment, for Medicaid-enrolled patients who have ED encounters. This cohort cohort study of 17, 428 Medicaid-enrolled patients demonstrated that the O-HQIP was associated with an increased initiation of buprenorphine in patients with OUD presenting to the ED. These findings suggest that statewide incentive programs may effectively improve outcomes for patients with OUD.
Published March 24, 2023
Sign up to receive our monthly Research Roundup email, which offers a selection of new public health research from major journals.
Recent Abstracts
Effects of Heat on Early Childhood Development
Blood Lead Surveillance of Children and Pregnant Women in Tamil Nadu, India
Sportswashing through Media: Coca-Cola’s Olympic Play – A Research Report
What’s in Our Food?
Mais Dados Mais Saúde
More Data, Better Health – Primary Health Care
Mais Dados Mais Saúde: Experiência De Discriminação Cotidiana Pela População Brasileira
More Data, Better Health – Experience of everyday Discrimination by the Brazilian population
Monitoramento de Estratégias pelo Fim da Violência contra Crianças e Adolescentes
Harm Reduction: The Neglected Pillar of US Drug Policy